Target intelligence / Profile preview

Small nuclear ribonucleoprotein polypeptide C pseudogene 13 (SNRPCP13)

Target
SNRPCP13
Molecular classification
Other (Pseudogene)
01

Overview

Small nuclear ribonucleoprotein polypeptide C pseudogene 13 (SNRPCP13) is a pseudogene of the SNRPC gene in humans. Pseudogenes are genomic DNA sequences similar to normal genes but typically non-functional; they often derive from protein-coding genes through duplication or mutation, but they do not encode functional proteins. The SNRPC gene encodes a specific component of the U1 small nuclear ribonucleoprotein (snRNP) particle, which is essential for pre-mRNA splicing, but the SNRPCP13 pseudogene does not appear to have coding capacity or therapeutic relevance. There is no evidence that SNRPCP13 is a therapeutic target, is involved in disease, or interacts with drugs. The only available information is its locus and classification as a pseudogene; no biological function or disease association is established for this pseudogene. SNRPCP13 is a pseudogene, not a protein, receptor, enzyme, transporter, or validated drug target. No reported biological function or disease association is linked specifically to SNRPCP13; it is distinguished from functional SNRPC protein and pseudogenes like SNRPFP1, which have described regulatory non-coding RNA activity in tumors. No aliases beyond its systematic name; no entries in drug-target or disease association databases; no biomarker or mechanism of action data. The query is "incorrect" in the context of therapeutic targeting as SNRPCP13 is a pseudogene, not a functional protein or targetable molecule. There are no data suggesting it is relevant as a receptor, enzyme, or drug target.

Other names
SNRPCP13

Beyond the preview

Go deeper on Small nuclear ribonucleoprotein polypeptide C pseudogene 13 (SNRPCP13).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Small nuclear ribonucleoprotein polypeptide C pseudogene 13 (SNRPCP13).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call